Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
Publishing timestamp: 2024-03-05 12:14:49
Summary
Novo Nordisk's drug Ozempic showed positive results in reducing the risk of kidney disease progression and related health complications in diabetic patients, leading to potential expanded approval and treatment opportunities.
Sentiment: POSITIVE
Keywords: novo nordisk a/s, pharmaceuticals, business, business news, biotech and pharmaceuticals, science, breaking news, eli lilly and co, health care industry, biotechnology,
Source: https://www.cnbc.com/2024/03/05/novo-nordisk-ozempic-cuts-risk-of-kidney-disease-progression.html